+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Computational assessment of deep-seated tumor treatment capability of the 9Be(d,n)10B reaction for accelerator-based boron neutron capture therapy (AB-BNCT)



Computational assessment of deep-seated tumor treatment capability of the 9Be(d,n)10B reaction for accelerator-based boron neutron capture therapy (AB-BNCT)



Physica Medica 30(2): 133-146



The 9Be(d,n)10B reaction was studied as an epithermal neutron source for brain tumor treatment through Boron Neutron Capture Therapy (BNCT). In BNCT, neutrons are classified according to their energies as thermal (<0.5 eV), epithermal (from 0.5 eV to 10 keV) or fast (>10 keV). For deep-seated tumors epithermal neutrons are needed. Since a fraction of the neutrons produced by this reaction are quite fast (up to 5-6 MeV, even for low-bombarding energies), an efficient beam shaping design is required. This task was carried out (1) by selecting the combinations of bombarding energy and target thickness that minimize the highest-energy neutron production; and (2) by the appropriate choice of the Beam Shaping Assembly (BSA) geometry, for each of the combinations found in (1). The BSA geometry was determined as the configuration that maximized the dose deliverable to the tumor in a 1 h treatment, within the constraints imposed by the healthy tissue dose adopted tolerance. Doses were calculated through the MCNP code. The highest dose deliverable to the tumor was found for an 8 μm target and a deuteron beam of 1.45 MeV. Tumor weighted doses ≥40 Gy can be delivered up to about 5 cm in depth, with a maximum value of 51 Gy at a depth of about 2 cm. This dose performance can be improved by relaxing the treatment time constraint and splitting the treatment into two 1-h sessions. These good treatment capabilities strengthen the prospects for a potential use of this reaction in BNCT.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052273458

Download citation: RISBibTeXText

PMID: 23880544

DOI: 10.1016/j.ejmp.2013.07.001


Related references

Impact of accelerator-based boron neutron capture therapy (AB-BNCT) on the treatment of multiple liver tumors and malignant pleural mesothelioma. RadioTherapy and Oncology 92(1): 89-95, 2009

Beam shaping assembly design of 7 Li(p,n) 7 Be neutron source for boron neutron capture therapy of deep-seated tumor. Applied Radiation and Isotopes 139: 316-324, 2018

A new approach for the synthesis of isonitrile carborane derivatives. Ligands for metal based boron neutron capture therapy (BNCT) and boron neutron capture synovectomy (BNCS) agents. Journal of Inorganic Biochemistry 85(1): 43-51, 2001

Radiation Chemical Yield of Hydroxyl Radicals for Accelerator-based Boron Neutron Capture Therapy: Dose Assessment of 10 B(n,α) 7 Li Reaction Using Coumarin-3-Carboxilic Solution. Radiation Research 191(5): 460-465, 2019

Study of moderator thickness for an accelerator-based neutron irradiation facility for boron neutron capture therapy using the 7 Li(p, n) reaction near threshold. Physics in Medicine and Biology 45(1): 59-67, 2000

Study of moderator thickness for an accelerator-based neutron irradiation facility for boron neutron capture therapy using the 7Li(p,n) reaction near threshold. Physics in Medicine and Biology 45(1): 59-67, 2000

Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT. Applied Radiation and Isotopes 67(7-8 Suppl): S313-S317, 2009

Boron neutron capture therapy (Bnct) for newly-diagnosed glioblastoma: Comparison of clinical results obtained with Bnct and conventional treatment. The Journal of Medical Investigation 61(3.4): 254-263, 2014

"Sequential" boron neutron capture therapy (BNCT): a novel approach to BNCT for the treatment of oral cancer in the hamster cheek pouch model. Radiation Research 175(4): 463-472, 2011

Boron neutron capture therapy (BNCT) for newly-diagnosed glioblastoma: comparison of clinical results obtained with BNCT and conventional treatment. Journal of Medical Investigation 61(3-4): 254-263, 2014

A review of boron neutron capture therapy (BNCT) and the design and dosimetry of a high-intensity, 24 keV, neutron beam for BNCT research. British Journal of Radiology 61(732): 1115-1126, 1988

Electroporation optimizes the uptake of boron-10 by tumor for boron neutron capture therapy (BNCT) mediated by GB-10: a boron biodistribution study in the hamster cheek pouch oral cancer model. Radiation and Environmental Biophysics 58(3): 455-467, 2019

A Monte Carlo dosimetry-based evaluation of the 7Li(p,n)7Be reaction near threshold for accelerator boron neutron capture therapy. Medical Physics 27(1): 192-202, 2000

A study on the optimum fast neutron flux for boron neutron capture therapy of deep-seated tumors. Applied Radiation and Isotopes 96: 45-51, 2015

Therapeutic Success of Boron Neutron Capture Therapy (Bnct) Mediated by a Chemically Non-Selective Boron Agent in an Experimental Model of Oral Cancer: A New Paradigm in Bnct Radiobiology. Radiation Research 166(2): 387-396, 2006